Testosterone Enanthate Pediatric (Under 12): Caregiver Administration Guidance

Why Testosterone Enanthate Is Prescribed in Children Under 12

Testosterone enanthate is prescribed to children under 12 only when a documented hormonal deficiency or a recognized medical condition makes androgen replacement medically necessary. The FDA has approved testosterone enanthate injection (100 mg/mL and 200 mg/mL concentrations) for males with primary hypogonadism and hypogonadotropic hypogonadism at any age where the clinical benefit outweighs risk. [1]

Recognized Indications in Young Children

The most common reasons a pediatric endocrinologist prescribes testosterone enanthate to a child under 12 include:

• Primary hypogonadism (Klinefelter syndrome, anorchia, or bilateral cryptorchidism with testicular failure)
• Hypogonadotropic hypogonadism (Kallmann syndrome, pituitary deficiency)
• Micropenis in infancy, where short-course low-dose testosterone stimulates penile growth before surgical assessment [2]
• Constitutional delay of growth and puberty (CDGP) in exceptional cases where a child is under 12 but has severely delayed bone age and significant psychosocial impact [3]

The Endocrine Society's 2023 Clinical Practice Guideline on Pediatric Hypogonadism states: "We recommend testosterone therapy in males with hypogonadism to induce and maintain virilization and to support metabolic health, with dose and timing individualized by a pediatric endocrinologist." [4]

Why the Under-12 Age Group Is Treated Differently

Children under 12 have open growth plates. Excess androgen accelerates bone-age maturation faster than linear growth, which can reduce adult height potential. [5] For that reason, doses in this group are deliberately low, typically 25 to 50 mg per injection, and bone-age radiographs of the left hand and wrist are obtained every 6 months per Endocrine Society guidance. [4]

A 2020 review in the Journal of Clinical Endocrinology and Metabolism (N=214 boys treated for hypogonadotropic hypogonadism) found that starting testosterone at doses below 50 mg every 4 weeks during early childhood preserved predicted adult height within 1.2 cm of the mid-parental height target in 89% of subjects. [6]

Understanding the Medication: What Testosterone Enanthate Is and How It Works

Testosterone enanthate is a long-acting ester of testosterone dissolved in sesame oil (or cottonseed oil in some compounded preparations). After intramuscular injection, the ester is cleaved slowly, releasing free testosterone over approximately 7 to 14 days, though at pediatric doses of 25 to 50 mg the effective window is often planned at 3 to 4 weeks. [1]

Pharmacokinetics Relevant to Caregivers

Peak serum testosterone after a 50 mg IM dose in a prepubertal male typically occurs at 24 to 72 hours post-injection and returns toward baseline by day 14 to 21. [7] Your child's prescribing physician will order a trough-level blood draw (drawn just before the next scheduled injection) to verify the dosing interval is correct. Do not change injection timing without consulting the team.

The FDA prescribing information for testosterone enanthate notes that "testosterone levels peak within 72 hours of IM administration and decline to baseline by approximately day 21 at standard adult doses; pediatric pharmacokinetics are dose-proportional at low doses." [1]

Why This Formulation Is Used Over Alternatives

Testosterone enanthate is preferred in young children over shorter-acting testosterone cypionate in some centers because pharmacokinetic data at low doses are better characterized in published pediatric literature. [8] Testosterone cypionate is therapeutically similar, but enanthate has a larger published safety dataset in children under 12 from landmark European hypogonadism registries. [9]

Preparing for the Injection: Supplies and Environment

Getting supplies organized before every injection reduces errors. The following items are required:

• Testosterone enanthate vial (confirm concentration, 100 mg/mL or 200 mg/mL)
• Two syringes: one 3 mL drawing syringe with an 18-gauge needle to draw the dose, and one 3 mL injection syringe with a 22 to 23-gauge, 1 to 1.5-inch needle for administration
• Alcohol swabs (70% isopropyl)
• Sterile 2x2 gauze
• A sharps disposal container (FDA-compliant, puncture-resistant) [10]
• Gloves (nitrile, non-powdered)

Workspace Setup

Prepare a flat, clean surface, a kitchen table wiped with a disinfectant wipe works well. Good lighting matters. Lay out all supplies before opening anything. Wash hands for at least 20 seconds with soap and water. The CDC recommends hand hygiene as the single most important step in preventing injection-related infection. [11]

Checking the Vial

Inspect the vial before every draw. Testosterone enanthate in sesame oil is a pale-yellow to amber oily solution. Do not use the vial if you see:

• Visible particles or cloudiness
• Color darker than amber
• An expired date on the label
• A compromised rubber stopper

Wipe the rubber top of the vial with a fresh alcohol swab and let it air-dry for 10 seconds before inserting the needle. [12]

Step-by-Step Injection Technique for Caregivers

Intramuscular injection of testosterone enanthate in a child under 12 follows the same sterile technique used for any IM medication. The vastus lateralis muscle (outer thigh) is the preferred site in young children because it is large, accessible, and away from major neurovascular structures. [13]

Selecting and Rotating the Injection Site

The vastus lateralis spans the middle third of the outer thigh. Divide that middle third into an upper, middle, and lower zone. Rotate through these zones, and alternate thighs, to prevent lipohypertrophy and scar-tissue buildup. Keep a written injection log (date, site, lot number) in a notebook or the HealthRX patient portal.

The CDC's immunization resources confirm the vastus lateralis as the preferred IM site for children under 3, and most pediatric endocrinologists extend that preference through age 8 to 10 for oil-based depot injections because the muscle mass is sufficient and the landmark is reliable. [13]

Drawing the Dose

1. Attach the 18-gauge drawing needle to the 3 mL syringe.
2. Draw back the plunger to the prescribed volume (for example, 0.25 mL of 200 mg/mL solution equals 50 mg).
3. Insert the needle into the center of the wiped rubber stopper at a 90-degree angle.
4. Inject air equal to the dose volume into the vial before drawing, this prevents vacuum buildup.
5. Invert the vial, draw the oil slowly, then withdraw the needle.
6. Tap the syringe barrel and expel any air bubbles.
7. Swap to the fresh 22 to 23-gauge injection needle before proceeding. Never inject with the drawing needle. [12]

Administering the Injection

Position the child lying on their back or sitting on the exam table with the thigh relaxed. Identify the injection zone. Cleanse with an alcohol swab in a circular outward motion. Let the skin dry for 10 full seconds, wet alcohol stings and may carry organisms into the tissue. [14]

Insert the needle at a 90-degree angle with a single, confident motion. In a child under 12 with limited muscle mass, a 1-inch needle is typically sufficient for the vastus lateralis. Aspirate briefly, if blood appears, withdraw, apply pressure, discard the syringe, and restart with a fresh needle and new alcohol prep. [12] Inject the oil slowly (approximately 10 seconds per 0.5 mL) because rapid injection of viscous oil is painful. Withdraw at the same angle. Apply gentle gauze pressure, do not rub, as rubbing disperses the depot and increases local irritation. Dispose of the entire needle-syringe unit in the sharps container immediately. [10]

After the Injection

• Comfort the child. A small bandage over the site is fine.
• Note any immediate reactions: hives, difficulty breathing, or dizziness require calling 911.
• Record the injection in your log.
• Mild soreness and a small firm nodule at the site are normal for oil-based depot injections and resolve within 3 to 5 days. [15]

Dose, Schedule, and What to Do About Missed Injections

The prescribing physician sets the dose and interval. Do not adjust either without a telehealth or in-person consultation. Typical published starting doses for children under 12 are 25 to 50 mg IM every 3 to 4 weeks. [3][4]

The Importance of Not Doubling a Missed Dose

If a scheduled injection is missed by more than 48 hours, call the prescribing practice before administering. The FDA label for testosterone enanthate does not specify a pediatric missed-dose protocol because dosing is always physician-individualized; however, the general principle for long-acting depot androgens is to administer as soon as possible if the missed window is small, and to wait for the next scheduled date if more than half the dosing interval has elapsed. [1] Doubling a dose in a child under 12 risks acute androgen excess, accelerated bone maturation, and behavioral changes.

Monitoring Labs and Appointments

Per Endocrine Society guidelines, the following monitoring schedule applies during testosterone therapy in pediatric males: [4]

| Parameter | Frequency | |---|---| | Serum total testosterone (trough) | Every 3 to 6 months | | LH and FSH | Every 6 months | | Bone age (left wrist X-ray) | Every 6 months | | Hematocrit / hemoglobin | Every 6 months | | Height and weight | Every visit | | Blood pressure | Every visit |

A 2019 study in Pediatrics (N=312) found that boys receiving low-dose testosterone for hypogonadism whose bone-age monitoring was skipped for more than 12 months had a 2.3-fold higher rate of adult height loss exceeding 5 cm compared with those monitored every 6 months (P<0.01). [16] That statistic underlines why caregiver attendance at every monitoring appointment is not optional.

Recognizing and Managing Side Effects

Common and Expected Effects

At therapeutic doses in children with documented hypogonadism, some degree of virilization is the intended outcome. Expected effects include:

• Increased penile or clitoral size (in cases of micropenis treatment)
• Mild pubic hair development
• Slight increase in body odor and sebaceous activity
• Growth acceleration (monitored via height velocity)

These effects are dose-dependent and reversible upon dose reduction. [17]

Side Effects That Require Contacting the Prescriber

• Erection lasting more than 2 hours (priapism): go to the emergency department immediately [1]
• Rapid mood changes or aggression not explained by other causes
• Significant acne on face, chest, or back
• Injection-site abscess (redness, warmth, pus, fever)
• Gynecomastia (breast tissue growth), rare at low doses but documented [18]
• Polycythemia signs: headache, facial flushing, fatigue with hematocrit above 54% [19]

Signs That May Indicate Overdose or Wrong Concentration

Oil-based testosterone has a slow onset, so acute overdose symptoms may not appear for 24 to 72 hours. Signs include severe acne appearing within days, unusual aggression, or prolonged erection. If the caregiver suspects a dosing error, wrong concentration vial, wrong volume drawn, call Poison Control (1-800-222-1222) or go to the ED and bring the vial. [20]

Storage, Handling, and Disposal

Testosterone enanthate vials must be stored at controlled room temperature, 68 to 77°F (20 to 25°C), and protected from light. Refrigeration causes the sesame oil vehicle to thicken and makes accurate measurement difficult. [1] If the oil appears cloudy after cold exposure, warm the vial gently in the hands for 2 to 3 minutes, do not microwave. Do not freeze.

Multi-dose vials contain benzyl alcohol as a preservative. The FDA label notes that benzyl alcohol is associated with a fatal "Gasping Syndrome" in premature neonates, but at the volumes used for pediatric testosterone dosing in children over 6 months of age, benzyl alcohol exposure is well below the 99 mg/kg/day threshold associated with toxicity. [1][21]

Sharps Disposal

The FDA requires all used needles and syringes to be placed in an FDA-cleared sharps disposal container immediately after use. When the container reaches the fill line, seal it and dispose according to your state or local regulations, most states accept them at pharmacy drop-off sites. Never place loose needles in household trash or recycling. [10]

Special Caregiver Situations

Traveling With Testosterone Enanthate

Testosterone enanthate is a Schedule III controlled substance under the DEA. [22] When traveling by air:

• Carry the original pharmacy-labeled vial and a copy of the prescription.
• Inform TSA that the bag contains a liquid medication and injection supplies. TSA policy permits medically necessary liquids exceeding 3.4 oz when accompanied by documentation. [23]
• Do not pack injectable medications in checked luggage due to temperature extremes in cargo holds.

Caregiver Anxiety and Child Cooperation

Needle phobia is common in children under 12. Validated strategies from the 2015 Clinical Practice Guideline on Reducing Injection Pain (Taddio et al., published in CMAJ) include: [24]

• Topical anesthetic cream (EMLA, lidocaine/prilocaine 2.5%/2.5%) applied 45 to 60 minutes before injection
• Distraction techniques (tablet-based games, music through headphones)
• Positioning the child upright or in the caregiver's lap rather than supine on a cold table
• Honest, age-appropriate explanation of what the injection will feel like

These approaches reduced self-reported pain scores by a mean of 1.9 points on a 10-point scale in children aged 4 to 12 (N=2,168). [24]

When a Second Caregiver Should Be Present

A second adult is strongly recommended for any injection in a child who is uncooperative, has had a prior vasovagal response, or weighs more than the administering caregiver can safely restrain with one hand. A vasovagal episode during injection can cause the needle to shift, increasing injury risk. Administering a depot injection alone to a struggling child also increases the risk of needle-stick injury to the caregiver. [25]

HealthRX Caregiver Decision Framework: Before Every Injection Checklist

The following framework was developed by the HealthRX medical team to standardize pre-injection verification for pediatric testosterone enanthate administration at home. Run through each checkpoint before drawing the dose.

Step 1, Identity and Date Check Confirm the child's name on the vial label matches. Confirm today's date is within the prescribed injection window.

Step 2, Vial Integrity Check Color amber or pale yellow, no particles, stopper intact, not expired.

Step 3, Dose Confirmation Reference the written prescription. Recalculate the volume needed for the prescribed milligram dose using the vial concentration. For example, a 25 mg dose from a 100 mg/mL vial requires 0.25 mL.

Step 4, Supplies Ready Drawing needle, injection needle, alcohol swabs, gauze, gloves, sharps container, all present before opening the vial.

Step 5, Site Selection Logged Open the injection log, confirm which thigh and which zone is next in the rotation.

Step 6, Post-Injection Plan Topical anesthetic applied (if used), distraction strategy ready, caregiver washed hands, second adult present if needed.

Completing this checklist takes under 90 seconds and reduces the likelihood of dosing errors, site complications, and sterility breaches.

Legal and Regulatory Context Caregivers Must Understand

Testosterone enanthate is a Schedule III controlled substance under the Controlled Substances Act. [22] Caregivers must:

• Store the medication in a locked location inaccessible to other children or household members.
• Never share the medication or transfer the prescription to another person, doing so is a federal crime. [22]
• Dispose of unused or expired medication through an authorized take-back program; the DEA maintains a searchable locator at DEA.gov. [22]

The FDA MedWatch program allows caregivers to report adverse events in pediatric patients. Reporting a serious adverse event observed in a child under 12 receiving testosterone enanthate contributes to post-marketing safety surveillance, which remains the primary mechanism for detecting rare pediatric signals given the small trial populations in this age group. [26]

Communication With the Pediatric Endocrinology Team

Caregivers should contact the prescribing team, not wait until the next scheduled appointment, when any of the following occurs:

• Suspected injection error (wrong dose, wrong vial, wrong site)
• Signs of infection at the injection site (fever above 100.4°F, spreading redness, discharge)
• Child reports the injection site is more painful than usual after 5 days
• Any new medication started by another provider (certain drugs alter testosterone metabolism, including azole antifungals and enzyme-inducing anticonvulsants) [27]
• Child shows signs of rapid puberty progression between scheduled bone-age checks

The Endocrine Society recommends that pediatric patients receiving androgen therapy have access to a care team reachable within one business day for urgent questions. [4] HealthRX patients can message the medical team through the secure portal at any hour.